全文获取类型
收费全文 | 4639篇 |
免费 | 316篇 |
国内免费 | 177篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 47篇 |
妇产科学 | 41篇 |
基础医学 | 406篇 |
口腔科学 | 9篇 |
临床医学 | 419篇 |
内科学 | 1331篇 |
皮肤病学 | 26篇 |
神经病学 | 247篇 |
特种医学 | 64篇 |
外科学 | 395篇 |
综合类 | 591篇 |
现状与发展 | 1篇 |
预防医学 | 81篇 |
眼科学 | 28篇 |
药学 | 1233篇 |
中国医学 | 166篇 |
肿瘤学 | 42篇 |
出版年
2024年 | 3篇 |
2023年 | 41篇 |
2022年 | 66篇 |
2021年 | 118篇 |
2020年 | 120篇 |
2019年 | 89篇 |
2018年 | 106篇 |
2017年 | 90篇 |
2016年 | 92篇 |
2015年 | 123篇 |
2014年 | 191篇 |
2013年 | 482篇 |
2012年 | 222篇 |
2011年 | 226篇 |
2010年 | 204篇 |
2009年 | 189篇 |
2008年 | 248篇 |
2007年 | 245篇 |
2006年 | 183篇 |
2005年 | 204篇 |
2004年 | 166篇 |
2003年 | 198篇 |
2002年 | 137篇 |
2001年 | 149篇 |
2000年 | 128篇 |
1999年 | 103篇 |
1998年 | 97篇 |
1997年 | 128篇 |
1996年 | 96篇 |
1995年 | 70篇 |
1994年 | 67篇 |
1993年 | 53篇 |
1992年 | 52篇 |
1991年 | 41篇 |
1990年 | 39篇 |
1989年 | 33篇 |
1988年 | 27篇 |
1987年 | 38篇 |
1986年 | 38篇 |
1985年 | 37篇 |
1984年 | 44篇 |
1983年 | 22篇 |
1982年 | 25篇 |
1981年 | 40篇 |
1980年 | 25篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1976年 | 6篇 |
1975年 | 4篇 |
1974年 | 9篇 |
排序方式: 共有5132条查询结果,搜索用时 0 毫秒
1.
Alexandra Katsimardou Konstantinos Imprialos Konstantinos Stavropoulos Alexandros Sachinidis Michalis Doumas 《Expert opinion on pharmacotherapy》2020,21(10):1241-1252
ABSTRACT
Introduction
Type 1 diabetes mellitus (T1DM) is a chronic, autoimmune disease that is characterized by total absence of insulin production. Hypertension is a common comorbidity in T1DM with complex pathophysiology, while it is also a well-recognized risk factor for the development of cardiovascular disease (CVD), as well as other microvascular diabetic complications. 相似文献2.
Wilbert S Aronow 《Expert opinion on pharmacotherapy》2016,17(2):205-215
Introduction: It is important to know how to treat hypertension in patients with coronary artery disease (CAD). The reason for the review was to update this treatment and to discuss the 2015 American Heart Association/American College of Cardiology/American Society of Hypertension 2015 guidelines of treatment of hypertension in patients with CAD.Areas covered: Studies between 1968 and 2015 were reviewed on treatment of hypertension in patients with CAD using a Medline search, and studies between 1977 and 2015 were reported. Hypertension should be treated with beta blockers and ACE inhibitors or angiotensin receptor blockers (ARBs). Long-acting nitrates are effective antianginal and anti-ischemic drugs. Calcium-channel blockers (CCBs) may be added if angina persists despite beta blockers and long-acting nitrates. The 2015 guidelines recommend that the blood pressure should be < 140/90 mm Hg in patients aged ≤ 80 years and the systolic blood pressure < 150 mm Hg if they are ≥ 80 years.Expert opinion: Hypertension in patients with CAD should be treated with beta blockers and ACE inhibitors or ARBs. Long-acting nitrates are effective antianginal and anti-ischemic drugs. CCBs may be added if angina persists despite beta blockers and long-acting nitrates. The blood pressure should be < 140/90 mm Hg in patients aged < 80 years and the systolic blood pressure < 150 mm Hg if they are ≥ 80 years. 相似文献
3.
Summary— KR31080 (2-butyl-5-methyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-3H-imidazo[4,5-b] pyridine) is a potent inhibitor of angiotensin type 1 (AT1 ) receptors in rabbit aorta and human recombinant AT1 receptors. In the isolated rabbit thoracic aorta, KR31080 caused a nonparallel shift to the right of the concentration-response curves to angiotensin II (All) with decreased maximal response (pD'2 = 10.1 ± 0.1), but had no effect on the contractile response induced by norepinephrine. KR31080 inhibited specific [125 I]AII binding to rabbit aortic membranes (AT, receptors) and [125 I][Sar1 , Ile8 ]AII binding to human recombinant AT1 receptors in a concentration-dependent manner with IC50 values of 0.84 ± 0.08 nM and 1.92 ± 0.15 nM, respectively, but did not inhibit specific [125 I)AII binding to bovine cerebellum membranes (ÀT2 receptors). In the Scatchard analysis, KR31080 interacted with rabbit aortic AT1 receptors in a competitive manner, similar to losartan. These results demonstrate that KR31080 is a potent and AT1 selective angiotensin receptor antagonist which exerts a competitive antagonism in the [125 I]AII binding assay and insurmountable AT1 receptor antagonism in the functional study. 相似文献
4.
四氧嘧啶诱发糖尿病大鼠血管紧张素的变化 总被引:1,自引:0,他引:1
实验观察了四氧嘧啶诱发糖尿病大鼠连续饲养110d后体内肾素一血管紧张素系统的变化。结果表明,血浆和心脏的血管紧张素Ⅱ含量无明显变化,而肾脏的AngⅡ含量却明显低于正常对照组。另外,心脏的心钠素(ANP)含量在糖尿病大鼠与正常对照组之间无差别,血中的糖化血红蛋白含量基本无变化。上述结果表明,糖尿病大鼠早期心脏可能无明显损伤,而肾脏的肾素一血管紧张素系统活性降低。 相似文献
5.
Shang-Jin Shi Hiromi Rakugi Koichi Higashimori Jitsuo Higaki Hiroshi Mikami Toshio Ogihara 《Clinical and experimental pharmacology & physiology》1994,21(10):767-773
1. We previously reported that angiotensin II release from the mesenteric arteries of Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) increased in a time-dependent manner as a result of the isolation of the arteries and perfusion. This phenomenon appeared to be due to the withdrawal of circulating angiotensin II (AII). 2. The purpose of the present study was to test the hypothesis that vascular AII generation may be negatively regulated by circulating AII in WKY and SHR, and to clarify the role of this vascular angiotensin II in the sustained hypertension of SHR following nephrectomy. 3. The mesenteric arteries from kidney-intact and nephrectomized WKY and SHR were perfused and the amount of AII released into the perfusate was measured. The effects of the angiotensin converting enzyme inhibitor, captopril, and the effects of supplementation of renal renin and circulating angiotensins to nephrectomized rats, by blood exchange between kidney-intact and nephrectomized rats, on AII release were examined to clarify the pathway of vascular AII generation after nephrectomy. 4. Nephrectomy caused augmentation of vascular AII release both in WKY and SHR in spite of the abolishment of circulating renin. Captopril reduced this enhanced release of AII, but blood exchange did not affect it. There was no significant difference in these responses between WKY and SHR. 5. These results suggest that WKY and SHR have in common a potent pathway for production of vascular AII in response to the withdrawal of circulating AII, although this pathway is not responsible for the sustained hypertension of SHR after nephrectomy. The precise pathophysiological role of this pathway remains to be elucidated. 相似文献
6.
K. A. Rolls P. A. Phillips K. Aldred K. J. Hardy 《Clinical and experimental pharmacology & physiology》1994,21(3):227-230
1. Since plasma renin activity is increased in cyclosporin A (CsA)-induced hypertension in the rat, the role of the vascular renin-angiotensin system (RAS) in CsA-induced hypertension was investigated in rat mesenteric resistance vessels. 2. Female Wistar rats received CsA (10 mg/kg per day, s.c.) or vehicle for 30 days. CsA treatment increased tail-cuff systolic blood pressure (CsA treated 135 ± 3 mmHg vs control 125 ± 1 mmHg, P<0.0001). 3. Mesenteric resistance arteries (200–300 μm) were isolated and mounted in a microvessel myograph. Concentration-response curves to tetradecapeptide renin substrate (10-11-10?6 mol/L), angiotensin I (10-l1-10?6 mol/L) and angiotensin II (10-12-10?6 mol/L) showed no differences between CsA-treated and control groups. 4. Mesenteric vascular angiotensin-converting enzyme (ACE) characteristics were determined by radioligand binding. There were no differences in the content or affinity of ACE between CsA-treated and control rats. 5. These results suggest that the mesenteric vascular RAS does not play a major role in CsA-induced hypertension in the rat. 相似文献
7.
8.
Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension 总被引:15,自引:0,他引:15
The renin-angiotensin system is involved in control of blood pressure and salt and fluid homeostasis. Genes for components of this system have been of major focus in research on the causation of the common, complex, polygenic trait, essential hypertension (HT). Association of an A→C variant at nucleotide 1166 of the angiotensin II type 1 receptor (AT1 R) gene with HT, but an absence of linkage of this locus with this disease, has been reported recently. Since confirmation in a different setting is imperative, we performed a cross-sectional case-control study of the A1166C variant in a well-characterized group of 108 Caucasian HT subjects with a strong family history (two affected parents) and early onset disease. Genotyping was by mismatch polymerase chain reaction/ Bfr I restriction fragment length polymorphism analysis. Frequency of the C1166 allele was 0.40 in HTs and 0.29 in normotensives. The difference in genotype (χ2 = 13, P = 0.0015) and allele (χ2 = 5.3, P = 0.02) frequencies between the two groups was significant (odds ratio for CC vs AA+AC = 7.3 [95% CI, 1.9–31.9). The present results implicate the AT1 R gene, or a locus in linkage disequilibrium with the variant tested, in the causation of essential HT. 相似文献
9.
用单侧输尿管梗阻的方法诱导小鼠肾间质纤维化,并从中成功地培养出了成纤维细胞。对成纤维细胞血管紧张素Ⅱ1A(AT1A)受体的表达与细胞增殖和分泌细胞外基质的关系进行了研究。结果发现,从肾间质纤维化组织中培养出的成纤维细胞,细胞增殖和产生纤维连接蛋白及层粘连蛋白的能力明显高于从正常肾间质中培养的成纤维细胞。在单侧输尿管梗阻小鼠的血浆和肾组织中血管紧张素Ⅱ的活性显著升高。从肾间质纤维化组织中培养出的成纤维细胞,AT1A受体的表达在蛋白质和分子水平上均有明显增高。表明,在肾间质纤维化过程中肾素-血管紧张素系统被激活,对刺激成纤维细胞增殖和产生细胞外基质起着重要作用。 相似文献
10.